交易笔记
顶级投资人
顶级投资人
国会交易
高管交易
顶级投资人
Warren Buffett
Cathie Wood
Li Lu
Ray Dalio
Bill Ackman
查看全部顶级投资人
历史归档
行业
AI & Compute
Software & Digital
Healthcare Innovation
Financial Infrastructure
Energy & Grid
Industrial Automation
Consumer & Commerce
Real Estate & Assets
Materials & Manufacturing
Listed Vehicles
AI & Compute
Semiconductors & Accelerators
Cloud & AI Platforms
Data Center & Networking
View all AI & Compute
研究
搜索
EN
LXRX
Lexicon Pharmaceuticals, Inc.
Insider Trades
Name
Value
Action
Price
Current Price
DR
Debbane Raymond
Director
$3.0k
2k shares
Buy
Feb 25, 2026
$1.49
--
DR
Debbane Raymond
Director
$147k
100k shares
Buy
Feb 23, 2026
$1.47
--
DR
Debbane Raymond
Director
$148k
100k shares
Buy
Feb 20, 2026
$1.48
--
DR
Debbane Raymond
Director
$72k
50k shares
Buy
Feb 19, 2026
$1.44
--
DR
Debbane Raymond
Director
$176k
133.7k shares
Buy
Feb 18, 2026
$1.32
--
DR
Debbane Raymond
Director
$101k
76.9k shares
Buy
Feb 17, 2026
$1.31
--
News
fool.com
Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026?
fool.com
Jun 11
globenewswire.com
Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions
globenewswire.com
Jun 3
globenewswire.com
Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
globenewswire.com
May 28
globenewswire.com
Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
globenewswire.com
May 12
marketbeat.com
Lexicon Pharmaceuticals Q1 Earnings Call Highlights
marketbeat.com
May 8